Different Impact of Essential Hypertension on Structural and Functional Age-Related Vascular Changes

Hypertension

Volumn 69, Issue 1, 2017, Pages 71-78

  Bruno, Rosa Maria ^a   Duranti, Emiliano ^a   Ippolito, Chiara ^a   Segnani, Cristina ^a   Bernardini, Nunzia ^a   Di Candio, Giulio ^a   Chiarugi, Massimo ^a   Taddei, Stefano ^a   Virdis, Agostino ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

endothelial dysfunction; microcirculation; nitric oxide; oxidant stress; remodeling

Indexed keywords

ACETYLCHOLINE; ANTIHYPERTENSIVE AGENT; CHOLESTEROL; COLLAGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TEMPOL; TRIACYLGLYCEROL;

ADULT; AGED; AGING; ARTERY; ARTICLE; BLOOD VESSEL FUNCTION; BLOOD VESSEL PARAMETERS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COLLAGEN FIBER; CONTROLLED STUDY; ENDOTHELIUM; ESSENTIAL HYPERTENSION; FEMALE; GROUPS BY AGE; HUMAN; HUMAN TISSUE; MALE; MEDIA LUMEN RATIO; MYOGRAPHY; OXIDATIVE STRESS; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; SKIN BIOPSY; STRUCTURE ANALYSIS; VASCULAR FIBROSIS; VASCULAR REMODELING; VASODILATATION; BIOPSY; CROSS-SECTIONAL STUDY; DISEASE COURSE; HYPERTENSION; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; YOUNG ADULT;

ADULT; AGED; AGING; ARTERIES; BIOPSY; COLLAGEN; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; VASCULAR REMODELING; VASODILATION; YOUNG ADULT;

EID: 84994085763     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.08041     Document Type: Article

References (35)

1. Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, Hamburg NM, Lüscher TF, Shechter M, Taddei S, Vita JA, Lerman A. The assessment of endothelial function: from research into clinical practice. Circulation. 2012;126:753-767. doi: 10.1161/ CIRCULATIONAHA.112.093245.
2. Ghiadoni L, Taddei S, Virdis A. Hypertension and endothelial dysfunction: therapeutic approach. Curr Vasc Pharmacol. 2012;10:42-60.
3. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, Sudano I, Salvetti A. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation. 1995;91:1981-1987.
4. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, Salvetti A. Age-related reduction of NO availability and oxidative stress in humans. Hypertension. 2001;38:274-279.
5. Christensen KL, Mulvany MJ. Location of resistance arteries. J Vasc Res. 2001;38:1-12. doi: 51024.
6. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens. 2004;17(12 Pt 1):1192-1200. doi: 10.1016/j.amjhyper.2004.05.023.
7. Rizzoni D, Porteri E, Guefi D, Piccoli A, Castellano M, Pasini G, Muiesan ML, Mulvany MJ, Rosei EA. Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension. Hypertension. 2000;35:931-935.
8. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A, Girelli A, Rodella L, Bianchi R, Sleiman I, Rosei EA. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation. 2001;103:1238-1244.
9. Endemann DH, Pu Q, De Ciuceis C, Savoia C, Virdis A, Neves MF, Touyz RM, Schiffrin EL. Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment. Hypertension. 2004;43:399-404. doi: 10.1161/01.HYP.0000112029.03691.e7.
10. Schiffrin EL, Hayoz D. How to assess vascular remodelling in small and medium-sized muscular arteries in humans. J Hypertens. 1997;15:571-584.
11. Virdis A, Savoia C, Grassi G, Lembo G, Vecchione C, Seravalle G, Taddei S, Volpe M, Rosei EA, Rizzoni D. Evaluation of microvascular structure in humans: a 'state-of-The-art' document of the Working Group on Macrovascular and Microvascular Alterations of the Italian Society of Arterial Hypertension. J Hypertens. 2014;32:2120-2129; discussion 2129. doi: 10.1097/HJH.0000000000000322.
12. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E. Prognostic significance of small-artery structure in hypertension. Circulation. 2003;108:2230-2235. doi: 10.1161/01.CIR.0000095031.51492.C5.
13. Virdis A, Colucci R, Neves MF, Rugani I, Aydinoglu F, Fornai M, Ippolito C, Antonioli L, Duranti E, Solini A, Bernardini N, Blandizzi C, Taddei S. Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition. Eur Heart J. 2012;33:2225-2234. doi: 10.1093/eurheartj/ehr138.
14. Wu J, Saleh MA, Kirabo A, et al. Immune activation caused by vascular oxidation promotes fibrosis and hypertension. J Clin Invest. 2016;126:50-67. doi: 10.1172/JCI80761.
15. Virdis A, Santini F, Colucci R, Duranti E, Salvetti G, Rugani I, Segnani C, Anselmino M, Bernardini N, Blandizzi C, Salvetti A, Pinchera A, Taddei S. Vascular generation of tumor necrosis factor-α reduces nitric oxide availability in small arteries from visceral fat of obese patients. J Am Coll Cardiol. 2011;58:238-247. doi: 10.1016/j.jacc.2011.01.050.
16. Virdis A, Bacca A, Colucci R, Duranti E, Fornai M, Materazzi G, Ippolito C, Bernardini N, Blandizzi C, Bernini G, Taddei S. Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation. Hypertension. 2013;62:337-344. doi: 10.1161/HYPERTENSIONAHA.111.00995.
17. Virdis A, Colucci R, Fornai M, Blandizzi C, Duranti E, Pinto S, Bernardini N, Segnani C, Antonioli L, Taddei S, Salvetti A, Del Tacca M. Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress. J Pharmacol Exp Ther. 2005;312:945-953. doi: 10.1124/jpet.104.077644.
18. Neves MF, Virdis A, Schiffrin EL. Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism. J Hypertens. 2003;21:189-198. doi: 10.1097/01.hjh.0000045515.82010.5a.
19. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension. 1993;21:391-397.
20. Virdis A, Duranti E, Colucci R, Ippolito C, Tirotta E, Lorenzini G, Bernardini N, Blandizzi C, Taddei S. Ghrelin restores nitric oxide availability in resistance circulation of essential hypertensive patients: role of NAD(P)H oxidase. Eur Heart J. 2015;36:3023-3030. doi: 10.1093/ eurheartj/ehv365.
21. Ippolito C, Colucci R, Segnani C, et al. Fibrotic and vascular remodelling of colonic wall in patients with active ulcerative colitis. J Crohns Colitis. 2016;10:1194-1204. doi: 10.1093/ecco-jcc/jjw076.
22. Rizzoni D, Muiesan ML, Porteri E, Castellano M, Zulli R, Bettoni G, Salvetti M, Monteduro C, Agabiti-Rosei E. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens. 1997;15:197-204.
23. Rizzoni D, Agabiti Rosei E. Small artery remodeling in hypertension and diabetes. Curr Hypertens Rep. 2006;8:90-95.
24. Lakatta EG. The reality of aging viewed from the arterial wall. Artery Res. 2013;7:73-80. doi: 10.1016/j.artres.2013.01.003.
25. Harvey A, Montezano AC, Touyz RM. Vascular biology of ageing-Implications in hypertension. J Mol Cell Cardiol. 2015;83:112-121. doi: 10.1016/j.yjmcc.2015.04.011.
26. Engelen L, Ferreira I, Stehouwer CD, Boutouyrie P, Laurent S; Reference Values for Arterial Measurements Collaboration. Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors. Eur Heart J. 2013;34:2368-2380. doi: 10.1093/ eurheartj/ehs380.
27. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, Hansson L, Magnani B, Rahn KH, Reid J, Rodicio J, Safar M, Eckes L, Ravinetto R. Risk factors associated with alterations in carotid intimamedia thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 1998;16:949-961.
28. Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension. 2009;54:1328-1336. doi: 10.1161/ HYPERTENSIONAHA.109.137653.
29. Reference Values for Arterial Stiffness C. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'Establishing normal and reference values'. Eur Heart J. 2010;31:2338-2350.
30. Cunha PG, Cotter J, Oliveira P, Vila I, Boutouyrie P, Laurent S, Nilsson PM, Scuteri A, Sousa N. Pulse wave velocity distribution in a cohort study: from arterial stiffness to early vascular aging. J Hypertens. 2015;33:1438-1445. doi: 10.1097/HJH.0000000000000565.
31. Mitchell GF. Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol (1985). 2008;105:1652-1660. doi: 10.1152/ japplphysiol.90549.2008.
32. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension. 2004;44:248-252. doi: 10.1161/01. HYP.0000138070.47616.9d.
33. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, Giulini SM, Agabiti-Rosei E. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension. 1996;28:785-790.
34. Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension. 2000;36:312-318.
35. Taddei S, Virdis A, Mattei P, Ghiadoni L, Fasolo CB, Sudano I, Salvetti A. Hypertension causes premature aging of endothelial function in humans. Hypertension. 1997;29:736-743.